Publicaciones en las que colabora con Josune Orbe Lopategui (11)

2022

  1. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1314-1325

2015

  1. Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury

    Blood, Vol. 126, Núm. 7, pp. 915-919

  2. Functional MMP-10 is required for efficient tissue repair after experimental hind limb ischemia

    FASEB Journal, Vol. 29, Núm. 3, pp. 960-972

2002

  1. Regulation by nitric oxide of endotoxin-induced tissue factor and plasminogen activator inhibitor-1 in endothelial cells

    Thrombosis and Haemostasis, Vol. 88, Núm. 6, pp. 1060-1065

2001

  1. Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty

    Cardiovascular Research, Vol. 49, Núm. 2, pp. 484-492

1999

  1. Effect of the administration of recombinant hirudin and/or tissue- plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits

    British Journal of Haematology, Vol. 105, Núm. 1, pp. 117-121

  2. Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits

    American Journal of Hematology, Vol. 60, Núm. 1, pp. 6-11

1998

  1. Infusion of anti-PAI-1 monoclonal antibodies to rabbits given endotoxin to induce DIG

    Fibrinolysis and Proteolysis, Vol. 12, Núm. SUPPL. 1, pp. 6

1997

  1. Other acquired hypercoagulable states

    Sangre, Vol. 42, Núm. 6, pp. 483-492

  2. Otros estados de hipercoagulabilidad adquiridos

    Sangre, Vol. 42, Núm. 6, pp. 482-492

1995

  1. Plasma thrombomodulin is increased in cord blood of healthy newborns [2]

    Thrombosis and Haemostasis